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Summary 
Granzymes are a family of granule-associated serine esterases that mediate apoptosis by cytotoxic 
T lymphocytes and natural killer cells. We have previously shown that cdc2, the mitosis-regulating 
cyclin-dependent kinase, is required for granzyme B-induced apoptosis in target cells. In addition, 
granzyme B induces premature activation and tyrosine dephosphorylation of cdc2 during apoptosis. 
Throughout most of the cell cycle and until the cell is prepared to enter mitosis, cdc2 kinase 
activity is negatively regulated by phosphorylation of a residue within its adenosine triphosphate- 
binding domain by Wee1, a nuclear kinase that maintains mitotic timing in eukaryotic cells. 
We have transiently expressed c-myc epitope-tagged V/eel cDNA in BHK cells. Cells that expressed 
Wed in the nucleus became resistant to apoptosis induced by granzyme B and perforin. Weel- 
transfected cells also exhibited markedly increased cdc2 tyrosine phosphorylation. Thus,  Weel 
can rescue cells from granzyme-induced apoptosis by preventing cdc2 dephosphorylation. 
G 
ranzymes A, B, and 3 induce apoptosis (1-3) in the pres- 
ence of the pore-forming protein perforin (1, 2).  Per- 
forin is required for CTL cytotoxicity (4-6) but does not it- 
self induce apoptosis (1, 2), while ablation of granzyme B 
function severely compromises CTL-induced apoptosis (3). 
Cells undergoing granzyme B-mediated apoptosis rapidly ac- 
tivate cdc2 (7),  a serine threonine kinase that is critical to 
G2/M  transition  and  mitosis  (8).  cdc2  kinase  activity  is 
tightly regulated by phosphorylation and dephosphorylation 
and by association with cyclins A or B. cdc2 binds to cyclin 
B during S and G2, and this complex remains inactive as a 
result of phosphorylation at Tyr  is within the ATP binding 
domain by wee1 and mikl kinase (9, 10) until mitosis, when 
cdc2 is dephosphorylated by cdc25 (11). 
It has been found that mammalian cells that inappropri- 
ately express  cdc2 or cdc25 undergo mitotic catastrophe, a 
phenomenon that morphologically resembles apoptosis (12, 
13). Cells undergoing apoptosis induced by granzyme B and 
perforin prematurely activate cdc2 kinase activity, and the 
expression ofcdc2 is necessary for the nuclear changes ofchro- 
matin condensation and DNA fragmentation that are typ- 
ical of apoptosis (7). We have therefore suggested that gran- 
zyme-induced apoptosis resembles mitotic catastrophe in that 
it results from expression of cdc2 outside of mitosis (7). Re- 
cently, Heald et al.  found that human p50  wee1 can protect 
the nucleus from abnormal mitotic timing as a result of aber- 
rant cdc2 or cdc25 activation (12).  In this study, we have 
tested the hypothesis that Wee1 regulates not only mitotic 
timing but also initiation of apoptosis by cdc2 phosphorylation. 
We show that Wed overexpression prevents cdc2 dephosphor- 
ylation and apoptosis mediated by granzyme B. 
Materials and Methods 
Cells and Antibodies.  Baby hamster kidney (BHK) cells were 
obtained from American Type Culture Collection (Rockvilh, MD) 
and maintained in RPMI 1640 and 10% FCS. Anti-c-myc anti- 
body was purchased from Santa Cruz Biotechnology Inc., (9El0; 
Santa Cruz, CA). Antiphosphotyrosine  antibody was purchased 
from Upstate Biotechnology, Inc. (4G10, Lake Placid, NY). The 
rabbit anti-cdc2 antibody was produced by immunization with a 
COOH-terminal synthetic peptide as described previously (7). 
Transient Transfections.  Plasmid  pWEE1 bearing a 5' c-myc epi- 
tope tag was obtained from Dr. Frank McKeon (Harvard Univer- 
sity, Boston, MA) and has been described previously (12). BHK 
cells (5  x  105) were plated onto 100 x  20-mm tissue culture 
dishes (Nunc, Koskilde, Denmark) in 10 ml of medium on day 1. 
On day 2, cesium chloride gradient- purified plasmid pWeel DNA 
was added to 500/~1 of 0.25-M CaClz and 20 mM Hepes and 
precipitated by dropping it slowly into 500/~1 of 2 x Hepes-buffered 
saline (2x  Hepes-buffered saline is 282  raM NaC1, 0.78  mM 
NazHPO4, and 50 mM Hepes, pH 7.1). After 20 min, 5 ml of 
complete medium was added to the mixture.  The medium was 
aspirated from each dish, replaced with the DNA mixture,  and 
allowed to incubate in a tissue culture incubator for 5 h. The cells 
were then washed twice with complete medium and incubated for 
an additional 12 h. BHK ceils were then trypsinized, washed, and 
resuspended in HBSS containing 2 mM CaCI2 and BSA (4 mg/ml, 
pH 7.4). Aliquots of 5  x  10  s ceils in 80 #1 were added to 80 #1 
of TEB (20 mM Tris-HC1, pH 7.2, 0.1 mM EGTA, and 140 mM 
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B and perforin. After 2 or 3 h incubation at 37~  cells were evalu- 
ated for c-myc/Weel staining and apoptosis. 
Imraunofluorescence  for c-myc/weel  Expression  and Chroraatin Con- 
densation.  BHK cells were centrifuged in 96-well V-bottomed mi- 
crotiter plates (5  x  10  s cells per well); the medium was aspirated; 
and cells were fixed in 150 #1 of 3% formaldehyde (Mallinckrodt 
Specialty Chemicals, Chesterfield, MO) in PBS and incubated for 
10 min at room temperature. Cells were washed twice with PBS 
containing 0.1% NP-40 (Sigma Chemical Co., St. Louis, MO) 
(PBS-NP-40). Primary 9E10 antibody was diluted in PBS-NP-40 
and incubated for I h while shaking, followed  by two washes with 
PBS-NP-40. FITC-conjugated goat anti-mouse IgG secondary  an- 
tibody (Sigma Chemical Co.) was also diluted in PBS-NP-40 and 
incubated for 30 min. DNA was labded using Hoechst dye at 
1 #g/ml in PBS-NP-40 for I min. Cells were resuspended  in.10/~1 
of 90%o glycerol, 10% 0.2 M "Iris (pH 8.0), mounted on glass slide, 
and examined on an axiovert fluorescence  microscope (Carl Zeiss, 
Inc., Thornwood, NY). Between 150 and 300 cells were counted 
for each incubation condition. 
Western Blotting and Imraunoprecipitation.  106 BHK cells treated 
with granzyme  B and perforin as described  above were washed  twice 
with cold PBS and extracted on ice with I ml of extraction buffer 
(50 mM/5-glycerophosphate, pH 7.3, 1% NP-40, 10 mM NaF, 
1% aprotinin, and 1 mM sodium vanadate) for 1 h. The lysates 
were centrifuged at 10,000 g for 20 min at 4oC, and the cdc2 was 
immunoprecipitated with 3 #1 of a rabbit antibody raised against 
the COOH-terminal peptide of cdc2 and 30 #1 of protein A beads 
(Bio-Rad Laboratories,  Richmond, CA) and rotated at 4~  for 1 h. 
In some  experiments, e~zess  cdc2 peptide was added to block precipi- 
tation as described previously (7). Precipitates were washed three 
times in buffer, and samples were fractiomted on an SDS-PAGE 
12% mini-gel (Bio-Rad  Laboratories)  and electrophoretically  trans- 
ferred to nitrocellulose  membrane (BA-S NC; Schleicher  & Schuell, 
Inc., Keene,  NH) using a multiphore  II electrophoresis system  (Phar- 
macia LKB Biotechnology, Inc., Piscataway,  NJ). The membranes 
were blocked for 1 h in PBS containing 2% BSA and incubated 
in antiphosphotyrosine 4G10 antibody diluted into the same solu- 
tion for 1 h. After three washes in blocking solution, membranes 
were incubated with goat anti-mouse conjugated to horseradish 
peroxidase for 1 h. Membranes were then washed four times and 
developed using chemiluminescence  substrates according to manu- 
facturer's instructions (ECL; Amersham  Corp., Arlington Heights, 
IL). For c-myc/Weel staining, 25 #1 of cell lysate  was fractionated 
on SDS-PAGE and transferred  to nitrocellulose  as above. Membranes 
were incubated with 9E10 mAb and developed as above. 
Results 
Transfection of  c-myc Epitope-tagged Weel Rescues  BHK Cells 
from Granzyme B-induced Apoptosis.  To maintain cdc2 ki- 
nase in an inactive phosphorylated state during granzyme B 
treatment, we transfected and overexpressed a Weel cDNA. 
Because Wee1 produces cell cycle arrest  due to cdc2 kinase 
inactivation, its effects could only be evaluated in transient 
transfection assays (12). For these experiments, the human 
p50 w~l kinase (14) that had been epitope-tagged with c-myc 
sequences recognized by 9E10 mouse mAbs was used (12). 
BHK cells were transfected either with weel or with vector 
and then washed and examined 12 h later. In repeated experi- 
ments using the calcium phosphate method, between 17 and 
22% of the cells transfected with Wee1 were positive for c-myc 
by direct fluorescence microscopy, and this was localized to 
the nucleus (Fig.  1, A  and C).  Weel or vector-transfected 
cells were treated with granzyme B  and perforin. After 2 
or 3 h incubation, a high proportion of the vector-transfected 
cells and Weel-transfected  cells that did not express Wee1 were 
apoptotic with intense chromatin condensation detected by 
Hoechst staining (Fig. 2). However, in Weel-expressing cells, 
we found only low levels of  chromatin condensation  just above 
the background of non-granzyme-treated cells, indicating that 
granzyme B-induced apoptosis had been almost completely 
inhibited (Fig.  1, A  and C; Fig. 2).  It was also found that 
cells that were calcium phosphate transfected with the empty 
vector exhibited levels of apoptosis between 20  and 22%. 
Simple calcium phosphate treatment without the vector pro- 
duced a similar result. This apoptosis was also reduced by 
up to 50% after Wee1 transf.ection,  and the total viable cell 
recovery was increased, indicating that Weel was protecting 
cells  from  apoptosis  induced during  calcium  phosphate- 
mediated transfection (Fig.  2). 
Weel Phosphorylates  cdc2 in Granzyme B-Treated BHK Cells. 
To determine the effect of Wee1 on cdc2 phosphorylation, 
we transfected BHK cells with either Weel or vector,  and 
then incubated with granzyme B and perforin as before. Cell 
lysates were precipitated with an antibody to the COOH 
terminus of cdc2, and the precipitate was examined by SDS- 
PAGE and Western blotting with either anti-cdc2 antibody 
or antiphosphotyrosine antibody 4G10. Western blots of cdc2 
tyrosine phosphorylation showed a dramatic increase in the 
Weel-transfected cells (Fig.  3, upper  panel). The identity of 
the cdc2 in the precipitates  was confirmed using peptide in- 
hibition of immunoprecipitation (Fig. 3, lane 4).  Weel and 
vector-transfected controls were examined by Western blot- 
ting for c-myc, and the predicted 50-kD band was detected 
only in the  /~el-transfected cells (Fig.  3,  lower  panel). 
Because we had detected apoptosis during vector transfec- 
tion by calcium phosphate treatment of BHK cells and rescue 
with Weel, we examined the state of cdc2 phosphorylation 
in these cells. It was evident that cdc2 tyrosine phosphoryla- 
tion decreased significantly after calcium phosphate transfec- 
tion,  and that  Wee1 transfection restored this to equal or 
slightly greater levels than those seen in untreated BHK cells 
(Fig. 4, upper  panel). The level of cdc2 protein was unchanged 
in cells transfected with Weel, indicating that the variations 
in cdc2 phosphorylation were not due to changes in cdc2 
protein levels (Fig.  4,  lower  panel). 
Discussion 
In these experiments, we have shown that wee1 overex- 
pression protects cells from granzyme B-induced apoptosis. 
The human p50 we~l exhibits homology to both wee1 and 
mikI (14), which are redundant kinases in Schizosaccharomyces 
pombe (15), and has been shown to rescue BHK cells over- 
producing the phosphatase cdc25,  or cdc2 and cyclin A or 
B (12). The coincident suppression of apoptosis and cdc2 phos- 
phorylation by Weel, combined with our earlier findings that 
suppression  of cdc2 expression abrogates apoptosis (7), indi- 
cates that cdc2 activation and dephosphorylation are neces- 
2296  Wee1 Rescue of Granzyme  B-induced Apoptosis Figure  1.  BHK cells expressing c-myc epitope-tagged weel are resistant to granzyme B and perforin. (A, C) Hoechst dye staining (B, D) anti-myc 
antibody. The Wee1 is detected by anti-myc antibody and is expressed  in the nucleus of transfected  cells. After addition of granzyme B (1,500 ng/ml) 
and perforin (65 ng/ml), BHK cells not expressing Wee1 undergo apoptosis identified by chromatin condensation using Hoeschst dye (solid arrows). 
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Figure  2.  Quantitation of apoptosis in BHK cells expressing wee1. Con- 
trol transfected BHK cells induced to undergo apoptosis by granzyme B 
and perforin at different  doses and times of treatment (Control). Cells that 
were transfected  with and expressed  c-myc  epitope-tagged Weel are resis- 
tant to apoptosis induced by granzyme B (Wee1  +), while those cells not 
expressing weel in the same transfection  were susceptible  (Wee1  -). In cells 
not treated with granzyme B, calcium  phosphate transfection  induced  low 
levels of apoptosis, which were suppressed by Wee1 transfection. Gran- 
zyme B was added at the doses indicated, and the perforin concentration 
was constant at 65 ng/ml.  Between 150 and 300 cells were counted for 
each condition. The experiment was repeated several times with similar 
results. 
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sary for apoptosis  induced by granzyme B.  In  addition,  it 
has been shown  that  when cdc25  and cyclin B  are overex- 
pressed and mitotic timing is abnormal, Wee1 can phosphory- 
late cdc2 and rescue the cells (12). Thus,  it is reasonable to 
conclude that p50  Wee1 kinase is dominant over cdc25 phos- 
phatase during granzyme B-induced apoptosis on the basis 
of the observed cdc2 rephosphorylation.  This suggests that 
the suppression of wee1 activity is likely to be necessary for 
the initiation of apoptosis and that granzyme B must be able 
to inactivate wee1. If wee1 is to be maintained in the inactive 
state,  niml  kinase (16-18), which inhibits wee1 activity by 
phosphorylation, may be activated, and/or phosphatases that 
activate wee1 by dephosphorylation may be inactivated. How 
granzyme B might do this is not known. However, to main- 
tain cdc2 in an active state during apoptosis, both wee1 inac- 
tivation and cdc25 activation are required. It seems unlikely 
that both proteins are proteolytically activated by granzyme 
B, but rather that  there is a  single substrate upstream  that 
initiates apoptosis and regulates both wee1 and cdc25 kinase 
activity. 
It was of additional interest  that  the low levels of apop- 
tosis and  the cdc2 dephosphorylation  after simple calcium 
phosphate transfection were also reversed by Wee1 transfec- 
Report Figure 3.  Weel  maintains  phosphorylation  of cdc2 during granzyme 
B-ind~__~_ apoptosis (upper  pane/). Phosphorylation of cdc2 by weel in 
granzyrae  B-treated  BHK cells. Cells were  tramfected  with Wiel (lanes 
2-4) or control vector  (lane I), and then treated with granzyme  B and 
perforin (lanes 1-4). Cell lysates  were precipitated  with anti-cdc2 anti- 
body. and membranes  weze  blotted with antiphosphotyrosine  mAb. In 
lane 4, eacess  cdc2 COOH-terminal  peptide was added to inhibit cdc2 
precipitation, myc-epitope  tagged Wee1 expression  (/ower  panel). Lysates 
of  vector-transfected  (lane 1) and W/el-transfected  BHK cells  (lanes  2-4) 
were blotted with anti-c-myc  mAb. 
tion. It has been suggested that an increase in cytoplasmic 
Ca  2+  is  an  early  signal  for  initiation  of apoptosis  by  a 
number of agents (19), although it is often not sufficient by 
itself (20). Thus, it is possible that Ca  2§  may contribute to 
other apoptosis signals through effects on cdc2 phosphoryla- 
tion. Granzyme B and perforin also require Ca  2  + to induce 
apoptosis (21). 
Although these data support  the hypothesis that  weel- 
induced cdc2 phosphorytation can rescue cells  from apop- 
tosis,  it cannot be concluded that this is the only effect of 
wee1. Premature induction of cyclin A-associated cdk2 ac- 
tivity has  also  been  observed in  apoptosis  (22),  and  p58 
PITSLRE, a distantly related cdc2 gene family member, in- 
duces apoptosis when overexpressed (23). Therefore, we cannot 
rule out the possibility that other cydin-dependent kinases 
(CDKs) participate in granzyme B-induced apoptosis,  and 
that Wed overexpression is phosphorylating and inhibiting 
these kinases in addition to cdc2. In either case, wee1 appears 
to play a key role in both control of  mitotic timing and apop- 
toffs mediated by CDKs. 
Recent evidence indicates that there must be more than 
one effector pathway for mediating apoptosis,  as cdc2 is used 
in some but not all forms of  apoptosis. Programmed cell death 
in postmitotic neurons can occur even though cdc2 is not 
expressed (24), and thymocytes treated with etoposide or dexa- 
methasone undergo apoptosis but do not contain increased 
Figure 4.  Dephosphotylation  of cdc2  by calcium  phosphate  transfec- 
tion and rephosphoryhtion  by Weel. (Upper  panel) Untreated  BHK cells 
(lane  S) ae compmd to ve~or-mmk'ted cells Oane  1) and Weel  -mnsfeaed 
cells (lanes  2-4). Lysates  were precipitated  with anti-eric2  antibody  and 
blotted with antiphosphotyrosine  mAb. (Loa~panet) cdc2  protein  levels 
in Weel-tranffected  cells remain  unchanged.  The membrane  represented 
in the upper panel was stripped and reprobed with anti-cdc2  antibody. 
levels ofcdc2 kinase activity (25). On the other hand, in ad- 
dition to our reports that premature cdc2 activation is re- 
quired for granzyme-induced  apoptosis,  Meikrantz et al. (22) 
found increased cdc2 and cdk2 kinase activity associated with 
cyclin A after TNF-~ and drug-induced apoptosis in hydroxy- 
urea-arrested HeLa ceils. Similarly, in ceUs  undergoing apoptosis 
after treatment with taxol, cdc2 kinase activity is coincidently 
increased (26). Recently, using the model of  activation-induced 
apoptosis after T call receptor cross-linking of a T call hybrid- 
oma, Fotedar et al.  (27)  have shown that cdc2/cyclin B ac- 
tivity is increased, and, using antisense oligonucleotides, that 
cyclin B expression is necessary for apoptosis.  Interestingly, 
they were unable to block dexamethasone-induced apoptosis, 
indicating that, in the same cell, only one form of apoptosis 
requires cdc2/cyclin B. Considering all of these data, it is likely 
that several members of the CDK family are effectors of apop- 
toffs,  including cdc2, cdk2, and p58PITSLRE,  although it 
is not known if they act independently of one another. 
If there are distinct CDK effector molecules for different 
forms of apoptosis,  then the view that there is a necessary 
and sufficient biochemical event for all forms of apoptosis 
may be challenged. Strasser et al. (28) have recently identified 
p53-independent  apoptosis  in  T  cells  undergoing  DNA 
damage, which again supports the idea that there is more 
than one apoptosis pathway for DNA damage. The family 
of three IL-lfl--converting enzyme (ICE) proteases, ICE (29), 
Ich-1 (30),  and CPP32 (31), that are the mammalian coun- 
terparts of ced.3 of Caenorhabditus  elegans may constitute a 
2298  FVeel Rescue  of Granzyme  B-induced Apoptosis common apoptosis pathway. However, with several members 
of the ICE family and several members of the CDK family 
implicated in apoptosis, it is equally plausible that more than 
one pathway exists and that individual members of these two 
families are used for initiating apoptosis in different cells or 
following specific initiating signals.  It is also not yet clear 
whether or not the CDK and ICE families are acting on the 
same pathways. In conclusion, our results indicate that one 
effector pathway, which is used by the granzymes, initiates 
apoptosis by the targeted disruption of cdc2 phosphorylation. 
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